Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應用:
(2S,3R,4R,5S)-6-((2-((2-((4-Cyanophenyl)amino)pyrimidin-4-yl)amino)-5-((E)-2-cyanovinyl)-3-(hydroxymethyl)benzyl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic Acid is a metabolite of Rilpivirine (R509800), which is a novel non-nucleoside reverse transcriptase inhibitor. Rilpivirine is an anti-HIV agent that seems to be well tolerated with less CNS disturbance than Efavirenz and has non-teratogenic potential.
?您的位置：
